KarXT for schizophrenia–effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KarXT for schizophrenia–effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council

Published:2024-06 Issue:6 Volume:30 Page:624-628
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

McKenna Avery¹,Tice Jeffrey A.²,Whittington Melanie D.³,Wright Abigail C.¹,Richardson Marina¹,Raymond Finn R.¹,Pearson Steven D.¹,Rind David M.¹,Agboola Foluso¹

Affiliation:

1. Institute for Clinical and Economic Review, Boston, MA.

2. Division of General Internal Medicine, Department of Medicine, University of California, San Francisco.

3. Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA.

Publisher

Academy of Managed Care Pharmacy

Reference8 articles.

1. The Economic Burden of Schizophrenia in the United States

2. Schizophrenia

3. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia

4. Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia

5. Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP